Home | Welcome to Contract Pharma   
Last Updated Saturday, May 23 2015


Financial Report: Sigma-Aldrich

Published February 7, 2013
4Q Revenues: $655 million (+7%)

4Q Earnings: $116 million (+7%)

FY Revenues: $2.6 billion (+5%)

FY Earnings: $460 million (+1%)

Comments: Growth in the quarter was driven by a 3% increase in Research and Sigma-Aldrich Fine Chemicals (SAFC) with sales growth of 2% and 5%, respectively. Acquisitions contributed 6% to sales growth.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On